NEW YORK, Nov. 11 (GenomeWeb News) - Galapagos Genomics said today that it has entered into a collaboration with Boehringer Ingelheim in the field of antiviral discovery research.

Boehringer Ingelheim will use Galapagos' SilenceSelect platform - a collection of adenoviruses with siRNA-based knockdown sequences targeting over 4,000 human genes -- to perform a genome-wide screen for all drugable genes that influence viral replication in human cells, Galapagos said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.